Home › Endometrial Cancer › NCT04570553

Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers

Who can join

Ages 18 and older · Women

Inclusion Criteria:

* Subjects age 18 or older able to give informed consent
* Biopsy diagnosed endometrial cancer (including endometrioid, serous, mucinous and clear cell histologies)
* Planned standard of care surgical management of early stage endometrial cancer
* No clinical evidence of disseminated intraperitoneal disease

Exclusion Criteria:

* Final pathology does not reflect diagnosis of endometrial cancer (including endometrioid, serous, mucinous, and clear cell histology)
* Evidence of disseminated intraperitoneal disease
* Subject is not a surgical candidate
* Subject elects for fertility sparing or non-operative management
* Subject is unable to provide informed consent

About the study

This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.

What is being tested

• surgical staging (procedure)

Sponsor: WellSpan Health · Participants: 350 · Started: Oct 15, 2020

Contact the study team

• Graham Brown, DO · Phone: 717-851-6120
• Eav Lim, DO · Phone: 717-851-6120

Official record on ClinicalTrials.gov — NCT04570553

Locations in the U.S.

Conditions

• Endometrial Cancer

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.